Temporal Changes in the Intestinal Growth Promoting Effects of Glucagon-Like Peptide 2 Following Intestinal Resection

Journal of Surgical Research

Volumn 152, Issue 2, 2009, Pages 271-280

  Kaji, Tatsuru ^a,b   Tanaka, Hiroaki ^a,c   Redstone, Heather ^a   Wallace, Laurie E ^a   Holst, Jens J ^d   Sigalet, David L ^a  

^a Institute of Inflammation Infection and Immunity   (Canada)

^b KAGOSHIMA UNIVERSITY   (Japan)

^c KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Crypt cell apoptosis; Crypt cell proliferation; enteric neurons; intestinal morphology; nutrients; SGLT 1

Indexed keywords

GLUCAGON LIKE PEPTIDE 2; GLUCOSE TRANSPORTER 2; GLUCOSE TRANSPORTER 5; GROWTH PROMOTOR; MESSENGER RNA; PROTEIN C FOS; RECEPTOR PROTEIN; SODIUM GLUCOSE COTRANSPORTER 1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BODY WEIGHT; CELL ACTIVATION; CELL COUNT; CELL PROLIFERATION; CONTROLLED STUDY; CRYPT CELL; DRUG EFFECT; EDEMA; FOLLOW UP; GROWTH; INTERMETHOD COMPARISON; INTESTINE; INTESTINE CRYPT; INTESTINE FUNCTION; INTESTINE MUCOSA; INTESTINE VILLUS; MALE; MORPHOLOGY; MORPHOMETRICS; NERVE CELL; NONHUMAN; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR UPREGULATION; SMALL INTESTINE RESECTION; TOTAL PARENTERAL NUTRITION; TREATMENT OUTCOME; URINE VOLUME; WEIGHT GAIN;

ANIMALS; CELL DIVISION; GLUCAGON-LIKE PEPTIDE 2; INTESTINE, SMALL; MALE; MODELS, ANIMAL; PARENTERAL NUTRITION, TOTAL; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 62249181588     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2008.05.007     Document Type: Article

References (36)

1. Steyermark A.C., Lamm M.M., and Diamond J. Quantitative evolutionary design of nutrient processing: Glucose. Proc Natl Acad Sci USA 99 (2002) 8754
2. Sigalet D.L. Short bowel syndrome in infants and children: An overview. Semin Pediatr Surg 10 (2001) 49
3. Williamson R.C. Intestinal adaptation (second of two parts). Mechanisms of control. N Engl J Med 298 (1978) 1444
4. Cisler J.J., and Buchman A.L. Intestinal adaptation in short bowel syndrome. J Investig Med 53 (2005) 402
5. Sigalet D.L., and Martin G.R. Hormonal therapy for short bowel syndrome. J Pediatr Surg 35 (2000) 360
6. Drucker D.J. Biological actions and therapeutic potential of the glucagon-like peptides. Gastroenterology 122 (2002) 531
7. Martin G.R., Wallace L.E., and Sigalet D.L. Glucagon-like peptide-2 induces intestinal adaptation in parenterally fed rats with short bowel syndrome. Am J Physiol Gastrointest Liver Physiol 286 (2004) G964
8. Martin G.R., Wallace L.E., Hartmann B., et al. Nutrient-stimulated GLP-2 release and crypt cell proliferation in experimental short bowel syndrome. Am J Physiol Gastrointest Liver Physiol 288 (2005) G431
9. Martin G.R., Beck P.L., and Sigalet D.L. Gut hormones and short bowel syndrome: The enigmatic role of glucagon-like peptide-2 in the regulation of intestinal adaptation. World J Gastroenterol 14 (2006) 4117
10. Sigalet D.L. ALX-0600 (NPS Allelix Corp). Curr Opin Investig Drugs 2 (2001) 505
11. Roberge J.N., and Brubaker P.L. Secretion of proglucagon-derived peptides in response to intestinal luminal nutrients. Endocrinology 128 (1991) 3169
12. Drucker D.J., Erlich P., Asa S.L., et al. Induction of intestinal epithelial proliferation by glucagon-like peptide 2. Proc Natl Acad Sci. USA 93 (1996) 7911
13. Rocca A.S., and Brubaker P.L. Role of the vagus nerve in mediating proximal nutrient-induced glucagon-like peptide-1 secretion. Endocrinology 140 (1999) 1687
14. Sigalet D.L., Wallace L.E., Holst J.J., et al. Enteric neural pathways mediate the anti-inflammatory actions of glucagon-like peptide 2. Am J Physiol Gastrointest Liver Physiol 293 (2007) G211
15. Dube P.E., Forse C.L., Bahrami J., et al. The essential role of insulin-like growth factor-1 in the intestinal tropic effects of glucagon-like peptide-2 in mice. Gastroenterology 131 (2006) 589
16. Jeppesen P.B., Sanguinetti E.L., Buchman A., et al. Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients. Gut 54 (2005) 1224
17. Nelson D.W., Liu X., Holst J.J., et al. Vagal afferents are essential for maximal resection induced intestinal adaptive growth in orally fed rats. Am J Physiol Regul Integr Comp Physiol 291 (2006) R1256
18. Sigalet D.L., Martin G., Meddings J., et al. GLP-2 levels in infants with intestinal dysfunction. Pediatr Res 56 (2004) 371
19. Menge H., Hopert R., Alexopoulos T., et al. Three-dimensional structure and cell kinetics at different sites of rat intestinal remnants during the early adaptive response to resection. Res Exp Med (Berlin) 181 (1982) 77
20. Dahly E.M., Guo Z., and Ney D.M. IGF-1 augments resection induced mucosal hyperplasia by altering enterocyte kinetics. Am J Physiol Integr Comp Physiol 285 (2003) 800
21. Petersen Y.M., Hartmann B., Holst J.J., et al. Introduction of enteral food increases plasma GLP-2 and decreases GLP-2 receptor mRNA abundance during pig development. J Nutr 133 (2003) 1781
22. Lovshin J., Yusta B., Iliopoulos I., et al. Ontogeny of the glucagon-like peptide-2 receptor axis in the developing rat intestine. Endocrinology 141 (2000) 4194-4201
23. Liu X., Nelson D.W., Holst J., et al. Synergistic effect of supplemental enteral nutrients and exogenous glucagon-like peptide 2 on intestinal adaptation in a rat model of short bowel syndrome. Am J Clin Nutr 84 (2006) 1142
24. Osaka T., Endo M., Yamakawa M., et al. Energy expenditure by intravenous administration of glucagon-like peptide-1 mediated by the lower brainstem and sympathoadrenal system. Peptides 26 (2005) 1623
25. Tang-Christensen M., Larsen P.J., Thulesen J., et al. The proglucagon-derived peptide, glucagon-like peptide-2, is a neurotransmitter involved in the regulation of food intake. Nat Med 6 (2000) 802
26. Wallace L.E., Sharkey K.A., Swain M.G., et al. Systemic GLP-2 signals satiety and differentially affects the central and enteric nervous system. Gastroenterology 126 (2004) A590
27. Scott R.B., Sheehan A., Chin B.C., et al. Hyperplasia of the muscularis propria in response to massive intestinal resection in rat. J Pediatr Gastroenterol Nutr 21 (1995) 399
28. Ljungmann K., Hartmann B., Kissmeyer-Nielsen P., et al. Time-dependent intestinal adaptation and GLP-2 alterations after small bowel resection in rats. Am J Physiol Gastrointest Liver Physiol 281 (2001) G779
29. Jeppesen P.B., Hartmann B., Thulesen J., et al. Elevated plasma glucagon-like peptide 1 and 2 concentrations in ileum resected short bowel patients with a preserved colon. Gut 47 (2000) 370
30. Amin H.J., Holst J., Hartmann B., et al. Functional ontogeny of the proglucagon derived peptide axis in the premature human neonate. Pediatrics 121 (2008) e180
31. Estall J.L., Yusta B., and Drucker D.J. Lipid raft-dependent glucagon-like peptide-2 receptor trafficking occurs independently of agonist-induced desensitization. Mol Biol Cell 15 (2004) 3673
32. Walsh N.A., Yusta B., DaCambra M.P., et al. Glucagon-like peptide-2 receptor activation in the rat intestinal mucosa. Endocrinology 144 (2003) 4385
33. Cheeseman C.I. Up-regulation of SGLT-1 transport activity in rat jejunum induced by GLP-2 infusion in vivo. Am J Physiol 273 (1997) R1965
34. Liefaard G., Heineman E., Molenaar J.C., et al. Prospective evaluation of the absorptive capacity of the bowel after major and minor resections in the neonate. J Pediatr Surg 30 (1995) 388
35. Sigalet D.L., Martin G.R., and Meddings J.B. 3-0 Methylglucose uptake as a marker of nutrient absorption and bowel length in pediatric patients. JPEN J Parenter Enteral Nutr 28 (2004) 158-162
36. Wales P.W., de Silva N., Kim J.H., et al. Neonatal short bowel syndrome: A cohort study. J Pediatr Surg 40 (2005) 755